DK1154757T3 - Fast-dispersing gelatin-free dosage forms - Google Patents

Fast-dispersing gelatin-free dosage forms

Info

Publication number
DK1154757T3
DK1154757T3 DK00908371T DK00908371T DK1154757T3 DK 1154757 T3 DK1154757 T3 DK 1154757T3 DK 00908371 T DK00908371 T DK 00908371T DK 00908371 T DK00908371 T DK 00908371T DK 1154757 T3 DK1154757 T3 DK 1154757T3
Authority
DK
Denmark
Prior art keywords
dosage forms
solid dosage
active ingredient
gelatin
fast
Prior art date
Application number
DK00908371T
Other languages
Danish (da)
Inventor
Leon Paul Grother
Owen James Murray
Richard Green
Patrick Kearney
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of DK1154757T3 publication Critical patent/DK1154757T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to fast dispersing solid dosage forms that preferably dissolve in the oral cavity within sixty (60), more preferably within thirty (30), most preferably within ten (10) seconds. A novel feature of the solid dosage forms according to the invention reside in the fact that the composition is essentially free or absolutely free of mammalian gelatin. It has been discovered that the use of certain modified starches at concentrations from 20 to 90 % by weight of the solid dosage form prepares dosage forms that are mechanically and chemically stable and are able to deliver higher concentrations of an active ingredient than the heretofore utilized gelatin based fast dispersing solid dosage forms. Further, the solid dosage forms according to the invention are obtainable by removing a solvent, such as water, from a mixture comprising an active ingredient, a modified starch and a matrix forming agent via freeze drying.
DK00908371T 1999-01-27 2000-01-27 Fast-dispersing gelatin-free dosage forms DK1154757T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9901819.4A GB9901819D0 (en) 1999-01-27 1999-01-27 Pharmaceutical compositions
PCT/US2000/001868 WO2000044351A1 (en) 1999-01-27 2000-01-27 Fast dispersing dosage forms free of gelatin

Publications (1)

Publication Number Publication Date
DK1154757T3 true DK1154757T3 (en) 2008-05-13

Family

ID=10846608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00908371T DK1154757T3 (en) 1999-01-27 2000-01-27 Fast-dispersing gelatin-free dosage forms

Country Status (25)

Country Link
EP (1) EP1154757B1 (en)
JP (1) JP4863336B2 (en)
KR (1) KR100852015B1 (en)
CN (1) CN1193740C (en)
AT (1) ATE382334T1 (en)
AU (1) AU768121B2 (en)
BG (1) BG65413B1 (en)
CA (1) CA2360647C (en)
CY (1) CY1107384T1 (en)
CZ (1) CZ301249B6 (en)
DE (1) DE60037653T2 (en)
DK (1) DK1154757T3 (en)
ES (1) ES2298129T3 (en)
GB (1) GB9901819D0 (en)
HK (1) HK1037536A1 (en)
HU (1) HU226557B1 (en)
IL (2) IL144412A0 (en)
IS (1) IS2678B (en)
NO (1) NO331253B1 (en)
PL (1) PL197462B1 (en)
PT (1) PT1154757E (en)
RU (1) RU2242968C2 (en)
TR (1) TR200102504T2 (en)
WO (1) WO2000044351A1 (en)
ZA (1) ZA200105930B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
US7550156B2 (en) 2001-11-23 2009-06-23 Rohm And Haas Company Optimised pellet formulations
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082T4 (en) * 2002-05-07 2015-04-30 Ferring B.V. PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE
DE10237459A1 (en) * 2002-08-16 2004-02-26 Beiersdorf Ag Cosmetic preparation containing active ingredients
MXPA05005528A (en) * 2002-11-26 2006-04-05 Alk Abello As Pharmaceutical allergen product.
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
ITRM20030288A1 (en) * 2003-06-10 2004-12-11 Valerio Cioli SUBLINGUAL ADMINISTRATION OF NON STEROID INFLAMMATORY (NSAID)
EP2322197A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
DE20321887U1 (en) 2003-11-10 2012-01-20 Allergan, Inc. Medicines comprising low doses of desmopressin
EP1530967B1 (en) 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
RU2008117396A (en) 2005-10-04 2009-11-10 Альк-Абелло А/С (Dk) SOLID VACCINE COMPOSITION
CN101548958B (en) * 2008-04-03 2012-10-17 万特制药(海南)有限公司 Dispersing tablet containing terbinafine hydrochloride
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT2296686E (en) 2008-05-21 2014-05-23 Ferring Bv Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DE102008051579A1 (en) * 2008-10-14 2010-04-15 Rhodia Acetow Gmbh Biodegradable plastic and use thereof
JP5752677B2 (en) 2009-05-19 2015-07-22 セルジーン コーポレイション Formulation of 4-amino-2- (2,6-dioxopiperidin-3-yl) isoindoline-1,3-dione
EP2442821B1 (en) 2009-06-18 2017-06-14 Allergan, Inc. Safe desmopressin administration
PL2493457T3 (en) 2009-10-30 2018-01-31 Ix Biopharma Ltd Fast dissolving solid dosage form
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JP5602936B2 (en) * 2010-03-29 2014-10-08 フイルメニツヒ ソシエテ アノニム Spray-dried crystalline active ingredient
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
RU2566269C2 (en) 2010-03-29 2015-10-20 Ферринг Б.В. Fast-dissolving pharmaceutical composition
JP6061859B2 (en) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー Oral vaccine fast-dissolving dosage form using starch
BR112014005134A2 (en) 2011-09-16 2017-04-18 Ferring Bv fast dissolving pharmaceutical composition
RU2497505C1 (en) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский New therapeutic composition for treating pain syndrome accompanying smooth muscle spasm
RU2503447C1 (en) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Drug preparation in form of orally dispersible tablet and method for making drug preparation
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN106259891A (en) * 2015-05-28 2017-01-04 上海旺旺食品集团有限公司 A kind of probiotic bacteria buccal tablet and preparation method thereof
RU2674765C2 (en) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Antifungal composition of eutectic type (options)
FI3562486T3 (en) 2016-12-31 2024-06-04 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
SG11202012772XA (en) 2018-06-27 2021-01-28 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NL8304133A (en) * 1983-12-01 1985-07-01 Unilever Nv WATER-IN-OIL EMULSIONS CONTAINING HYDRATED STARCH GRAINS.
DE4018247A1 (en) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts MANUFACTURING METHOD FOR QUICK-DISINFITTING FILM-SHAPED PHARMACEUTICAL FORMS
DE69429119T2 (en) * 1993-07-09 2002-07-18 R.P. Scherer Corp., Troy METHOD FOR PRODUCING FREEZER DRIED DRUG DOSAGE FORMS
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
AU713462B2 (en) * 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
JP4292588B2 (en) * 1997-01-31 2009-07-08 日産化学工業株式会社 Oral formulation of pyridazinone compounds

Also Published As

Publication number Publication date
WO2000044351A1 (en) 2000-08-03
ATE382334T1 (en) 2008-01-15
HUP0105107A3 (en) 2006-07-28
DE60037653D1 (en) 2008-02-14
HUP0105107A2 (en) 2002-06-29
PL197462B1 (en) 2008-04-30
HU226557B1 (en) 2009-03-30
RU2242968C2 (en) 2004-12-27
JP4863336B2 (en) 2012-01-25
KR100852015B1 (en) 2008-08-12
EP1154757B1 (en) 2008-01-02
HK1037536A1 (en) 2002-02-15
ES2298129T3 (en) 2008-05-16
DE60037653T2 (en) 2008-10-30
EP1154757A1 (en) 2001-11-21
AU2972900A (en) 2000-08-18
CZ20012700A3 (en) 2002-08-14
EP1154757A4 (en) 2004-01-21
JP2003529535A (en) 2003-10-07
ZA200105930B (en) 2002-10-18
IL144412A0 (en) 2002-12-01
CA2360647C (en) 2005-08-02
CN1193740C (en) 2005-03-23
TR200102504T2 (en) 2002-08-21
IS2678B (en) 2010-09-15
IS6023A (en) 2001-07-25
GB9901819D0 (en) 1999-03-17
CZ301249B6 (en) 2009-12-23
PT1154757E (en) 2008-03-17
NO20013679L (en) 2001-09-19
CY1107384T1 (en) 2012-01-25
IL144412A (en) 2006-06-11
BG105739A (en) 2002-06-28
KR20010111565A (en) 2001-12-19
NO331253B1 (en) 2011-11-07
BG65413B1 (en) 2008-07-31
CN1337876A (en) 2002-02-27
AU768121B2 (en) 2003-12-04
NO20013679D0 (en) 2001-07-26
CA2360647A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
DK1154757T3 (en) Fast-dispersing gelatin-free dosage forms
NO980669L (en) Oral fast-soluble compositions for dopamine agonists
ATE219659T1 (en) USE OF GELABLE PHARMACEUTICAL COMPOSITIONS IN PERIODONTOLOGY
ATE234634T1 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULPHOALKYL ETHERCYCLODEXTRIN AND A THERAPEUTIC ACTIVE INGREDIENT
HUP0000141A2 (en) Process for producing the pellets containing at most 90 mass per cent medicative agent
FI842528A0 (en) FASTA PHARMACEUTICAL PREPARATION FRAON VILKA FRIGOERINGEN AV DET AKTIVA AEMNET SKER LAONGSAMT VIA REGLERAD YTEROSION.
BE901994A (en) TABLETS OF FAST DELITTING PHARMACEUTICAL ACTIVE INGREDIENTS, STABLE ON STORAGE.
CO5261593A1 (en) FORMULATIONS TO LOW DOSE AND USE
DE69808463D1 (en) SELF-MULULATING FORMULATION CONTAINING ACID LIPOPHILE COMPOUNDS
EA200700055A1 (en) PREPARATIVE FORMS OF ORAL FORMAL MEMANTINE FORMS WITH IMMEDIATE DELIVERY
KR880004803A (en) Spray dried acetaminophen
AR018607A1 (en) PHARMACEUTICAL PREPARATION THAT IN QUALITY OF ACTIVE INGREDIENT CONTAINS SODIUM LEVOTIROXIN, AND A PROCEDURE FOR ITS PREPARATION
HUP0203121A2 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
ATE444739T1 (en) POLYMER COMPOSITION AND DOSAGE FORMS CONTAINING SAME
RU2005117626A (en) IMPROVED READY-FORMED MEDICINAL FORMS CONTAINING SUBSTITUTED IMIDAZOLE DERIVATIVES
MY101266A (en) Pharmaceutical formulations
AR036323A1 (en) QUICK FORMS OF QUICK DISPERSION, FREE OF GELATINE
DK1155014T3 (en) New benzimidazole compounds for use as active therapeutic agents, processes for the preparation of these compounds and pharmaceutical compositions comprising them
JPS5278887A (en) Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil